This site is intended for health professionals only

UCB announce convertible bond offering increase


Following the successful placement of its senior unsecured convertible bonds, due 2015 (the “Bonds”) on 30 September, 2009, UCB SA announces the full exercise of the €50 million over-allotment option by Barclays Capital, BNP Paribas Fortis, and KBC Financial Products as Joint Bookrunners. The exercise of the over-allotment option increases the aggregate principal amount of the offering from €450 million to €500 million.

The net proceeds from the issue of the Bonds will be used by UCB for general corporate purposes and form part of a funding diversification policy being implemented by the Board.

Payment for and delivery of the Bonds are expected to take place on or about October 22 2009. The payment and delivery are subject to customary conditions for this type of transaction.

Application has been made to the Luxembourg Stock Exchange to list the Bonds on the official list of the Luxembourg Stock Exchange and to admit the Bonds to trading on the Luxembourg Stock Exchange’s Euro MTF Market, barring unforeseen circumstances.


Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine